Gandouling in the Treatment of Wilson's Disease

Status:
Not yet recruiting

Trial end date:
2024-12-31

Target enrollment:

Participant gender:

To evaluate the efficacy and safety of gandouling tablet in the treatment of clinical symptoms of Wilson's diasease.

Phase 4

Jun Li